Price History
Feb 9, 2026 — May 21, 2026Investment Snapshot
- Trading 13% below Graham Number — thin margin of safety
- Piotroski F-Score 7/9 — financially strong with improving fundamentals
- ROE of 9.6% — below-average profitability
Enhabit, Inc. (EHAB) is a Healthcare company operating in Services-Home Health Care Services, listed on the NYSE , with a market capitalisation of $707 million . Key value metrics: P/E ratio 13.3, P/B ratio 1.28, Piotroski F-Score 7 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Enhabit, Inc. — Fundamental Analysis Summary
Enhabit, Inc. (EHAB) is trading 13% below its Graham Number of $15.90, offering a thin margin of safety. The stock carries a reasonable trailing P/E ratio of 13.3x.
On financial health, EHAB shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and modest return on equity of 9.6% (sector average: -20.6%), and manageable leverage with a debt-to-equity ratio of 0.77.
StockPik's composite Value Score for EHAB is 98/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
EHAB shows revenue growing at 2% year-over-year, with earnings growing at 97%.